Patent details

EP3534908 Title: 9-AMINOMETHYL MINOCYCLINE COMPOUNDS AND USE THEREOF IN TREATING COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (CABP)

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
07/08/2025
Unitary Effect Status:
Unitary Effect Registered
Request Unitary Effect Accepted:
09/09/2025
Unitary Effect Date:
09/07/2025
Unitary Effect Registration Date:
09/09/2025
Request Unitary Effect Rejected:
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Unitary Effect Request Withdrawal Date:
Unitary Effect request has been accepted, please see the UPP register at the EPO for up-to-date information
UPP register:
EP3534908
SPC Number:
Creation Date:

Basic Information

Publication number:
EP3534908
WO Application Number:
US2017059165
Type:
European Patent Granted for NL
Status:
Unitary Effect Registered
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17867238.2
WO Publication Number:
WO2018085216
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
31/10/2017
Grant date:
09/07/2025
EP Publication Date:
11/09/2019
WO Publication Date:
11/05/2018
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
09/07/2025
EP B1 Publication Date:
09/07/2025
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
30/10/2037
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
09/07/2025
 
 

 

Name:
Paratek Pharmaceuticals, Inc.
Address:
75 Park Plaza, 3rd Floor, Boston, MA 02116, United States of America (US)

Inventor

1

Name:
TZANIS, Evangelos L.
Address:
Newtown Square PA 19073, United States of America (US)

2

Name:
MCGOVERN, Paul
Address:
Berwyn PA 19312, United States of America (US)

3

Name:
MANLEY, Amy
Address:
Phoenixville PA 19460 , United States of America (US)

4

Name:
GARRITY-RYAN, Lynne
Address:
Melrose MA 02176, United States of America (US)

5

Name:
TANAKA, S. Ken
Address:
Bellevue WA 98004, United States of America (US)

Priority

1

Priority Patent Number:
201762514415 P
Priority Date:
02/06/2017
Priority Country:
United States of America (US)

2

Priority Patent Number:
201762500611 P
Priority Date:
03/05/2017
Priority Country:
United States of America (US)

3

Priority Patent Number:
201762480516 P
Priority Date:
02/04/2017
Priority Country:
United States of America (US)

4

Priority Patent Number:
201662422843 P
Priority Date:
16/11/2016
Priority Country:
United States of America (US)

5

Priority Patent Number:
201662416010 P
Priority Date:
01/11/2016
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/65; C07C 237/26; A61P 31/04; A61P 11/00;

Publication

Bulletin

1

Bulletin Heading:
UP1
Journal edition number:
41/25
Publication date:
08/10/2025
Description:
European patents with registered Unitary Effect

2

Bulletin Heading:
EP2
Journal edition number:
28/25
Publication date:
09/07/2025
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202541
Publication date:
08/10/2025
Description:
Unitary Effect Request Acceptance

2

Issue number:
202537
Publication date:
10/09/2025
Description:
Unitary Effect Request Receipt

3

Issue number:
202528
Publication date:
09/07/2025
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type